Muniojus Tablets – Supportive Therapy for HIV Positive Patients
Improves non-specific and acquired immunity; deficiency of which is seen in HIV infections.
Helps in preventing opportunistic infections.
Useful in delaying the progress of disease.
Acts as an anti-oxidant.
Muniojus is a research product containing more than 70 herbo-mineral ingredients, which are selected and formulated in such a way as to act at different levels of the body. Most of the ingredients in the formulation have proven immuno-modulatory activity. Some of them are potent immuno-stimulators; thereby improving non-specific and also acquired immunity; deficiency of which is seen in HIV infections.
Various research works carried on some of the ingredients of the formulation show that these are effective in reducing disease progression, increase CD4 cell count, improve host resistance and probably reduce viral load. Some ingredients have proven antiviral activities and are found to be useful in delaying the progress of disease.
This product has been sent for trial to several institutions in India and abroad, and the initial reports are very promising.
- Ashwagandha (Withania somnifera)
- Nimba (Azadirachta indica)
- Shuddha Shilajatu
- Dhataki (Woodfordia fruticosa)
DOSAGE: 2 Tablets Twice Daily
Muniojus Tablet does not contain any additives, not even to form the tablet (non-coated, non-capsulated).